Technology News and Research

RSS

Get the best out of your microplate reader: recommendations for use

In this interview, NewsMed talks to Ann-Cathrin Volz and Martin Mangold about Microplate Reader and Recommendations for use.

From BMG LABTECH GmbH 17 May 2024

FDA clears Nova’s Stat Profile Prime Plus analyzer for micro capillary sample mode

Nova Biomedical is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for a micro capillary sample mode on the Stat Profile Prime Plus® Critical Care analyzer.

From Nova Biomedical 17 May 2024

Varenicline shows promise in first U.S. trial for e-cigarette cessation

The first U.S. trial of varenicline for e-cigarette cessation shows promising results and warrants larger-scale trials, the researchers say.

17 May 2024

USC researcher receives $3.1M to study early brain development in babies born to diabetic mothers

It has long been understood that pregnant women with diabetes are more likely to have children with obesity than women who do not have diabetes during pregnancy.

16 May 2024

Validation study shows positive reception for SkinNTDs app in Ghana and Kenya

The Journal of Medical Internet Research, a leading publication in digital health research, has published the results from the first phase of the validation study on the SkinNTDs mobile app, which aims to help control neglected tropical diseases and some common skin diseases, which particularly affect countries with low per capita incomes.

16 May 2024

SMART researchers identify key mechanism behind artemisinin resistance in malaria

Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-MIT Alliance for Research and Technology (SMART), MIT's research enterprise in Singapore, in collaboration with Massachusetts Institute of Technology (MIT), Columbia University Irving Medical Center (CUIMC), and Nanyang Technological University, Singapore (NTU Singapore), have discovered a link between malaria parasites' ability to develop resistance to antimalarial drugs – specifically artemisinin (ART) – through a cellular process called transfer Ribonucleic acid (tRNA) modification.

16 May 2024

Loneliness increases the risk of developing mental health problems

Are lonely people more likely to have problems with mental health? Yes, but the obverse is also true.

16 May 2024

Study demonstrates link between disrupted developmental dopamine signaling and ASD

Recent evidence suggests that dopamine plays a crucial role in neural development. In a novel study, investigators demonstrated the link between disrupted developmental dopamine signaling and autism spectrum disorder (ASD).

16 May 2024

Chiropractic care reduces tramadol prescriptions for sciatica, study finds

A new study led by researchers at University Hospitals Connor Whole Health found that adults initially receiving chiropractic spinal manipulation for newly diagnosed radicular low back pain (sciatica) were significantly less likely to be prescribed tramadol over the following year compared to those receiving usual medical care.

16 May 2024

Repurposing human-approved drugs for prion disease treatment

Prions are the abnormal, pathogenic agents that are transmissible and are able to induce abnormal folding of specific normal cellular proteins.

16 May 2024

Unveiling the role of neutrophils in lung cancer progression

Lung cancer remains a leading global health concern, responsible for the highest number of cancer-related deaths worldwide.

16 May 2024

Mechanistic insights into the role of huc-mscs in treating acute liver failure

Acute liver failure (ALF) is a life-threatening clinical problem with limited treatment options. Administration of human umbilical cord mesenchymal stem cells (hUC-MSCs) may be a promising approach for ALF.

16 May 2024

Sensing a Healthier Future with Sustainable Nanomaterials and Biosensors

In this interview conducted at Pittcon 2024 in San Diego, we spoke to this year's Keynote Speaker Professor Omowunmi (Wunmi) Sadik about how sustainable nanomaterials are transforming human health.

From Pittcon 16 May 2024

Closed Loop Medicine and Pharmanovia commence OptiZest study for their first precision medicine combination therapeutic

Closed Loop Medicine Ltd, a leading TechBio company developing combination prescription drug plus software therapy products that deliver personalized dose optimization, and Pharmanovia, a global pharmaceutical company that commercializes novel medicines and revitalizes, extends and expands the lifecycle of established medicines, today announced the initiation of their OptiZest study, ID: NCT06372470, and first patient recruitment.

From Closed Loop Medicine 16 May 2024

Azenta opens the doors to its new genomics laboratory in Oxford, UK

Azenta, Inc. today announced the grand opening of the new Genomics Laboratory in Oxford, UK, expanding its global reach of GENEWIZ Multiomics & Synthesis Solutions further in the UK market.

From Azenta Life Sciences 16 May 2024

Rapid Novor teams up with PMCC to evaluate EasyM™ for multiple myeloma minimal residual disease monitoring

Rapid Novor Inc., a global leader in mass spectrometry (MS)-based antibody protein sequencing, today announced that the first patient has been enrolled in a new clinical study titled 'Clinical evaluation of EasyM™ for disease response analysis in newly diagnosed MM patients (NDMM)'.

From Rapid Novor Inc 16 May 2024

California’S $12 billion Medicaid makeover banks on nonprofits’ buy-in

For much of his young life, Jorge Sanchez regularly gasped for air, at times coughing so violently that he'd almost throw up. His mother whisked him to the emergency room late at night and slept with him to make sure he didn't stop breathing.

16 May 2024

DeNovix releases new budget-friendly 1 µL UV-Vis spectrophotometer

DeNovix introduces the DS-7 Spectrophotometer, a new 1 uL UV-Vis spectrophotometer in the DS-Series Quantification Range.

From DeNovix Inc. 16 May 2024

RedShiftBio launches Aurora TX: Revolutionizing RNA and protein analysis with ultra-sensitive microfluidic modulation spectroscopy and thermal ramping capability

RedShiftBio, a leader in innovative biophysical characterization and bioprocess analytical solutions, proudly announces the launch of Aurora TX at The Protein & Antibody Engineering Summit (PEGS), kicking off on May 13, 2024, in Boston, MA. Aurora TX is the company's latest, most advanced instrument featuring ground-breaking MMS technology, and sets a new standard in biomolecular analysis by providing ultra-sensitive, ultra-precise measurements of biomolecule structure and stability, now enhanced with the addition of thermal ramping capability.

From RedShiftBio 16 May 2024

Nanoscribe partners with Advanced BioMatrix to offer 4 new bioresins for Quantum X bio

Nanoscribe and Advanced BioMatrix have joined forces to pioneer the field of bioprinting with the launch of four advanced bioresins tailored for Two-Photon Polymerization (2PP) based 3D printing.

From Advanced BioMatrix, Inc. 16 May 2024

1
2
3
4
...
2650
Next

Technology News and Research

Get the best out of your microplate reader: recommendations for use

FDA clears Nova’s Stat Profile Prime Plus analyzer for micro capillary sample mode

Varenicline shows promise in first U.S. trial for e-cigarette cessation

USC researcher receives $3.1M to study early brain development in babies born to diabetic mothers

Validation study shows positive reception for SkinNTDs app in Ghana and Kenya

SMART researchers identify key mechanism behind artemisinin resistance in malaria

Loneliness increases the risk of developing mental health problems

Study demonstrates link between disrupted developmental dopamine signaling and ASD

Chiropractic care reduces tramadol prescriptions for sciatica, study finds

Repurposing human-approved drugs for prion disease treatment

Unveiling the role of neutrophils in lung cancer progression

Mechanistic insights into the role of huc-mscs in treating acute liver failure

Sensing a Healthier Future with Sustainable Nanomaterials and Biosensors

Closed Loop Medicine and Pharmanovia commence OptiZest study for their first precision medicine combination therapeutic

Azenta opens the doors to its new genomics laboratory in Oxford, UK

Rapid Novor teams up with PMCC to evaluate EasyM™ for multiple myeloma minimal residual disease monitoring

California’S $12 billion Medicaid makeover banks on nonprofits’ buy-in

DeNovix releases new budget-friendly 1 µL UV-Vis spectrophotometer

RedShiftBio launches Aurora TX: Revolutionizing RNA and protein analysis with ultra-sensitive microfluidic modulation spectroscopy and thermal ramping capability

Nanoscribe partners with Advanced BioMatrix to offer 4 new bioresins for Quantum X bio

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News